Global Drug Discovery Software Market By Product Type, By Product Application, By Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2022 To 2030

Published : Q1 2022 | Pages : 200+

Select License Type


Description

Key Companies

Epocrates (United States)
Thermo Scientific Nautilus LIMS (United States)
ChemDraw (PerkinElmer) (United States)
MicroTracker (Norway)
DrugPatentWatch (United States)
AutoDock (Scripps Research) (United States)
Collaborative Drug Discovery Inc. (United States)
DrugDev Spark (United States)
DSG Drug Safety (United States)
PEPID PDC (United States)
Schrodinger Discovery Informatics Suite (United States)
Advera Health (United States)
American Gene Technologies (United States)
Aurora Drug Discovery Software (United States)
BIOVIA Discovery Studio (United States)

Segmentation Covered

By Application
Pharmaceutical Industry
Biotechnology Industry

By Deployment Mode
Cloud Based
Web Based

By Organization Size
Small & Medium Size Organizations
Large Organizations

By End Users
R&D scientists
Clinical trial organizers, managers, analysts

By Region

Asia-Pacific: China, Southeast Asia, India, Japan, Korea, Oceania
Europe : Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland
North America : United States, Canada, Mexico
Middle East & Africa : GCC, North Africa, South Africa
South America : Brazil, Argentina, Columbia, Chile, Peru

TABLE OF CONTENTS

Chapter 1 Global Drug Discovery Software Market Overview

1.1 Introduction
1.2 Taxonomy
1.2.1 By Product Type & End User
1.2.2 By Region
1.3 Drivers for Drug Discovery Software Market
1.4 Restraints for Drug Discovery Software Market
1.5 Opportunities for Drug Discovery Software Market
1.6 Trends for Drug Discovery Software Market
1.7 COVID-19 Impact Assessment on Drug Discovery Software Industry
1.8 Macro-economic Factors
1.9 Regulatory Framework
1.10 Pricing Analysis by Region, 2020
1.11 Opportunity Map Analysis
1.12 Opportunity Orbits
1.13 Market Investment Feasibility Index
1.14 PEST Analysis
1.15 PORTERS Five Force Analysis
1.16 Go to Market Strategy
1.17 Value Chain Analysis
1.18 Cost Structure Analysis
1.19 Regional Market Share and BPS Analysis

Chapter 2 Global Drug Discovery Software Market Overview

2.1 Global Drug Discovery Software Market by Product Type
2.1.1 Global Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
2.1.2 Global Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
2.1.3 Global Drug Discovery Software Market Attractiveness Analysis by Product Type, (2013-2020)
2.2 Global Drug Discovery Software Market by End User
2.2.1 Global Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
2.2.2 Global Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
2.2.3 Global Drug Discovery Software Market Attractiveness Analysis by End User, (2013-2020)
2.3 Global Drug Discovery Software Market by Region
2.3.1 Global Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
2.3.2 Global Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
2.3.3 Global Drug Discovery Software Market Attractiveness Analysis by Region, (2013-2020)
2.4 Global Drug Discovery Software Market Outlook (2013-2029)
2.4.1 Global Drug Discovery Software Market Value (US$ Mn) and Volume (Units) (2013-2020)
2.4.2 Global Drug Discovery Software Market Value (US$ Mn) and Volume (Units) (2021-2029)
2.5 Global Drug Discovery Software Market Value (US$ Mn) and Volume (Units) by Regions
2.5.1 Global Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
2.5.2 Global Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
2.6 Global Drug Discovery Software Market Value (US$ Mn) and Volume (Units) by Product Type
2.6.1 Global Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
2.6.2 Global Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
2.7 Global Drug Discovery Software Market Value (US$ Mn) and Volume (Units) by End User
2.7.1 Global Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
2.7.2 Global Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
2.8 Global Drug Discovery Software Market Y-o-Y Growth Rate Comparison (2014-2029)
2.8.1 Global Drug Discovery Software Market Y-o-Y Growth Rate by Region
2.8.2 Global Drug Discovery Software Market Y-o-Y Growth Rate by Product Type
2.8.3 Global Drug Discovery Software Market Y-o-Y Growth Rate by End User
2.9 Global Drug Discovery Software Market Share Comparison (2013-2029)
2.9.1 Global Drug Discovery Software Market Share by Region
2.9.2 Global Drug Discovery Software Market Share by Product Type
2.9.3 Global Drug Discovery Software Market Share by End User

Chapter 3 North America Drug Discovery Software Market Overview

3.1 North America Drug Discovery Software Market by Product Type
3.1.1 North America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
3.1.2 North America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
3.1.3 North America Drug Discovery Software Market Attractiveness Analysis by Product Type, (2013-2020)
3.2 North America Drug Discovery Software Market by End User
3.2.1 North America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
3.2.2 North America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
3.2.3 North America Drug Discovery Software Market Attractiveness Analysis by End User, (2013-2020)
3.3 North America Drug Discovery Software Market by Region
3.3.1 North America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
3.3.2 North America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
3.3.3 North America Drug Discovery Software Market Attractiveness Analysis by Region, (2013-2020)
3.4 North America Drug Discovery Software Market Outlook (2013-2029)
3.4.1 North America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) (2013-2020)
3.4.2 North America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) (2021-2029)
3.5 North America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) by Regions
3.5.1 North America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
3.5.2 North America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
3.6 North America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) by Product Type
3.6.1 North America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
3.6.2 North America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
3.7 North America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) by End User
3.7.1 North America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
3.7.2 North America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
3.8 North America Drug Discovery Software Market Y-o-Y Growth Rate Comparison (2014-2029)
3.8.1 North America Drug Discovery Software Market Y-o-Y Growth Rate by Region
3.8.2 North America Drug Discovery Software Market Y-o-Y Growth Rate by Product Type
3.8.3 North America Drug Discovery Software Market Y-o-Y Growth Rate by End User
3.9 North America Drug Discovery Software Market Share Comparison (2013-2029)
3.9.1 North America Drug Discovery Software Market Share by Region
3.9.2 North America Drug Discovery Software Market Share by Product Type
3.9.3 North America Drug Discovery Software Market Share by End User

Chapter 4 Europe Drug Discovery Software Market Overview

4.1 Europe Drug Discovery Software Market by Product Type
4.1.1 Europe Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
4.1.2 Europe Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
4.1.3 Europe Drug Discovery Software Market Attractiveness Analysis by Product Type, (2013-2020)
4.2 Europe Drug Discovery Software Market by End User
4.2.1 Europe Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
4.2.2 Europe Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
4.2.3 Europe Drug Discovery Software Market Attractiveness Analysis by End User, (2013-2020)
4.3 Europe Drug Discovery Software Market by Region
4.3.1 Europe Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
4.3.2 Europe Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
4.3.3 Europe Drug Discovery Software Market Attractiveness Analysis by Region, (2013-2020)
4.4 Europe Drug Discovery Software Market Outlook (2013-2029)
4.4.1 Europe Drug Discovery Software Market Value (US$ Mn) and Volume (Units) (2013-2020)
4.4.2 Europe Drug Discovery Software Market Value (US$ Mn) and Volume (Units) (2021-2029)
4.5 Europe Drug Discovery Software Market Value (US$ Mn) and Volume (Units) by Regions
4.5.1 Europe Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
4.5.2 Europe Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
4.6 Europe Drug Discovery Software Market Value (US$ Mn) and Volume (Units) by Product Type
4.6.1 Europe Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
4.6.2 Europe Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
4.7 Europe Drug Discovery Software Market Value (US$ Mn) and Volume (Units) by End User
4.7.1 Europe Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
4.7.2 Europe Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
4.8 Europe Drug Discovery Software Market Y-o-Y Growth Rate Comparison (2014-2029)
4.8.1 Europe Drug Discovery Software Market Y-o-Y Growth Rate by Region
4.8.2 Europe Drug Discovery Software Market Y-o-Y Growth Rate by Product Type
4.8.3 Europe Drug Discovery Software Market Y-o-Y Growth Rate by End User
4.9 Europe Drug Discovery Software Market Share Comparison (2013-2029)
4.9.1 Europe Drug Discovery Software Market Share by Region
4.9.2 Europe Drug Discovery Software Market Share by Product Type
4.9.3 Europe Drug Discovery Software Market Share by End User

Chapter 5 Asia Pacific Drug Discovery Software Market Overview

5.1 Asia Pacific Drug Discovery Software Market by Product Type
5.1.1 Asia Pacific Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
5.1.2 Asia Pacific Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
5.1.3 Asia Pacific Drug Discovery Software Market Attractiveness Analysis by Product Type, (2013-2020)
5.2 Asia Pacific Drug Discovery Software Market by End User
5.2.1 Asia Pacific Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
5.2.2 Asia Pacific Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
5.2.3 Asia Pacific Drug Discovery Software Market Attractiveness Analysis by End User, (2013-2020)
5.3 Asia Pacific Drug Discovery Software Market by Region
5.3.1 Asia Pacific Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
5.3.2 Asia Pacific Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
5.3.3 Asia Pacific Drug Discovery Software Market Attractiveness Analysis by Region, (2013-2020)
5.4 Asia Pacific Drug Discovery Software Market Outlook (2013-2029)
5.4.1 Asia Pacific Drug Discovery Software Market Value (US$ Mn) and Volume (Units) (2013-2020)
5.4.2 Asia Pacific Drug Discovery Software Market Value (US$ Mn) and Volume (Units) (2021-2029)
5.5 Asia Pacific Drug Discovery Software Market Value (US$ Mn) and Volume (Units) by Regions
5.5.1 Asia Pacific Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
5.5.2 Asia Pacific Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
5.6 Asia Pacific Drug Discovery Software Market Value (US$ Mn) and Volume (Units) by Product Type
5.6.1 Asia Pacific Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
5.6.2 Asia Pacific Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
5.7 Asia Pacific Drug Discovery Software Market Value (US$ Mn) and Volume (Units) by End User
5.7.1 Asia Pacific Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
5.7.2 Asia Pacific Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
5.8 Asia Pacific Drug Discovery Software Market Y-o-Y Growth Rate Comparison (2014-2029)
5.8.1 Asia Pacific Drug Discovery Software Market Y-o-Y Growth Rate by Region
5.8.2 Asia Pacific Drug Discovery Software Market Y-o-Y Growth Rate by Product Type
5.8.3 Asia Pacific Drug Discovery Software Market Y-o-Y Growth Rate by End User
5.9 Asia Pacific Drug Discovery Software Market Share Comparison (2013-2029)
5.9.1 Asia Pacific Drug Discovery Software Market Share by Region
5.9.2 Asia Pacific Drug Discovery Software Market Share by Product Type
5.9.3 Asia Pacific Drug Discovery Software Market Share by End User

Chapter 6 South America Drug Discovery Software Market Overview

6.1 South America Drug Discovery Software Market by Product Type
6.1.1 South America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
6.1.2 South America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
6.1.3 South America Drug Discovery Software Market Attractiveness Analysis by Product Type, (2013-2020)
6.2 South America Drug Discovery Software Market by End User
6.2.1 South America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
6.2.2 South America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
6.2.3 South America Drug Discovery Software Market Attractiveness Analysis by End User, (2013-2020)
6.3 South America Drug Discovery Software Market by Region
6.3.1 South America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
6.3.2 South America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
6.3.3 South America Drug Discovery Software Market Attractiveness Analysis by Region, (2013-2020)
6.4 South America Drug Discovery Software Market Outlook (2013-2029)
6.4.1 South America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) (2013-2020)
6.4.2 South America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) (2021-2029)
6.5 South America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) by Regions
6.5.1 South America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
6.5.2 South America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
6.6 South America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) by Product Type
6.6.1 South America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
6.6.2 South America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
6.7 South America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) by End User
6.7.1 South America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
6.7.2 South America Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
6.8 South America Drug Discovery Software Market Y-o-Y Growth Rate Comparison (2014-2029)
6.8.1 South America Drug Discovery Software Market Y-o-Y Growth Rate by Region
6.8.2 South America Drug Discovery Software Market Y-o-Y Growth Rate by Product Type
6.8.3 South America Drug Discovery Software Market Y-o-Y Growth Rate by End User
6.9 South America Drug Discovery Software Market Share Comparison 2013-2029
6.9.1 South America Drug Discovery Software Market Share by Region
6.9.2 South America Drug Discovery Software Market Share by Product Type
6.9.3 South America Drug Discovery Software Market Share by End User

Chapter 7 MEA Drug Discovery Software Market Overview

7.1 MEA Drug Discovery Software Market by Product Type
7.1.1 MEA Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
7.1.2 MEA Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
7.1.3 MEA Drug Discovery Software Market Attractiveness Analysis by Product Type, (2013-2020)
7.2 MEA Drug Discovery Software Market by End User
7.2.1 MEA Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
7.2.2 MEA Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
7.2.3 MEA Drug Discovery Software Market Attractiveness Analysis by End User, (2013-2020)
7.3 MEA Drug Discovery Software Market by Region
7.3.1 MEA Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
7.3.2 MEA Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
7.3.3 MEA Drug Discovery Software Market Attractiveness Analysis by Region, (2013-2020)
7.4 MEA Drug Discovery Software Market Outlook (2013-2029)
7.4.1 MEA Drug Discovery Software Market Value (US$ Mn) and Volume (Units) (2013-2020)
7.4.2 MEA Drug Discovery Software Market Value (US$ Mn) and Volume (Units) (2021-2029)
7.5 MEA Drug Discovery Software Market Value (US$ Mn) and Volume (Units) by Regions
7.5.1 MEA Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
7.5.2 MEA Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
7.6 MEA Drug Discovery Software Market Value (US$ Mn) and Volume (Units) by Product Type
7.6.1 MEA Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
7.6.2 MEA Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
7.7 MEA Drug Discovery Software Market Value (US$ Mn) and Volume (Units) by End User
7.7.1 MEA Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
7.7.2 MEA Drug Discovery Software Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
7.8 MEA Drug Discovery Software Market Y-o-Y Growth Rate Comparison (2014-2029)
7.8.1 MEA Drug Discovery Software Market Y-o-Y Growth Rate by Region
7.8.2 MEA Drug Discovery Software Market Y-o-Y Growth Rate by Product Type
7.8.3 MEA Drug Discovery Software Market Y-o-Y Growth Rate by End User
7.9 MEA Drug Discovery Software Market Share Comparison (2013-2029)
7.9.1 MEA Drug Discovery Software Market Share by Region
7.9.2 MEA Drug Discovery Software Market Share by Product Type
7.9.3 MEA Drug Discovery Software Market Share by End User

Chapter 8 Global Drug Discovery Software Market Company Profiles

8.1 Market Competition Scenario Analysis, By Company
8.2 Competitor Landscape
8.3 Company Share Analysis
8.4 Company Profiles
8.4.1 Company
8.4.1.1 Company Overview
8.4.1.2 Business Description
8.4.1.3 Product Portfolio
8.4.1.4 Key Financials
8.4.1.5 Key Developments
8.4.1.6 SWOT Analysis

Companies Included:
Epocrates (United States)
Thermo Scientific Nautilus LIMS (United States)
ChemDraw (PerkinElmer) (United States)
MicroTracker (Norway)
DrugPatentWatch (United States)
AutoDock (Scripps Research) (United States)
Collaborative Drug Discovery Inc. (United States)
DrugDev Spark (United States)
DSG Drug Safety (United States)
PEPID PDC (United States)
Schrodinger Discovery Informatics Suite (United States)
Advera Health (United States)
American Gene Technologies (United States)
Aurora Drug Discovery Software (United States)
BIOVIA Discovery Studio (United States)

Chapter 9 Methodology and Data Source

9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources

FOR MORE INFORMATION

Have a Question? Email us at

[email protected]

Or call us on

+1(925)478-7203

Credence Research Reports